Safety concerns about adulterated drug ingredients
May 17, 2011 in MedicationsGovernment regulators and pharmaceutical companies are moving to address a major new risk for the global supply of medicines: The possibility that unsafe ingredients are entering the supply chain as pharmaceutical companies increasingly outsource the production of drug ingredients to third parties. That's the topic of the cover story in the current edition of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.
C&EN Senior Editor Rick Mullin explains that the jolt for action came from several incidents. One incident —a major 2008 recall of contaminated heparin that likely caused 81 deaths in the U.S. In another incident, more than 300 people died in Panama after taking cough medicine manufactured with diethylene glycol that was shipped by a supplier as glycerin.
The story describes awareness within the U.S. Food and Drug Administration (FDA) that rampant globalization in drug manufacturing has outstripped the agency's resources for inspecting foreign facilities. FDA has responded by establishing an information sharing network with European, Japanese, and Australian regulators and has opened regional offices in Asia and elsewhere.
More information: http://pubs.acs.or … 20cover.html
Provided by
American Chemical Society
-
Reducing gene-damaging impurities in medicines
Sep 29, 2010 |
not rated yet |
0
-
Drug industry embraces new business strategies after tough year
Dec 09, 2009 |
not rated yet |
0
-
Heparin recall spreads in Europe
Mar 27, 2008 |
not rated yet |
0
-
Drug industry, nonprofits join forces to fight world's neglected diseases
Nov 11, 2009 |
not rated yet |
0
-
Recalls, food worries spark booming business in food safety
Dec 02, 2009 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (3) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Your brain on 'shrooms: fMRI elucidates neural correlates of psilocybin psychedelic state
Feb 29, 2012 |
4.9 / 5 (42) |
45
-
A question about drug tolerance
12 hours ago
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
-
portable metabolism meter?
May 21, 2012
-
Rare medical conditions on 20/20 tonight
May 18, 2012
-
"Good" Cholesterol in Doubt
May 17, 2012
- More from Physics Forums - Medical Sciences
More news stories
Aspirin may prevent recurrence of deep vein blood clots
(HealthDay) -- After suffering a type of blood clot called a venous thromboembolism, patients usually take a blood-thinner such as warfarin (Coumadin). But aspirin may do just as well after a period of time, ...
Medications
13 hours ago |
not rated yet |
1
|
Patients may receive too much acetaminophen in hospital
(HealthDay) -- Roughly 2.5 percent of admitted hospital patients may receive more than the safe daily cumulative dose of the pain-reliever acetaminophen, best known as Tylenol, on at least one day, according ...
Medications
13 hours ago |
1 / 5 (1) |
0
New quality standards limiting elemental impurities in medicines announced
As part of its ongoing efforts to help ensure the quality of medicines, the U.S. Pharmacopeial Convention (USP) has announced two new standards related to elemental impurities: General Chapters Elemental Impurities—Limits and ...
Medications
15 hours ago |
not rated yet |
0
Quality standards for heparin further strengthened
To help further secure a safe supply of the widely–used blood thinner heparin, a third round of revisions to quality standards for the drug has been advanced by the U.S. Pharmacopeial Convention (USP). USP's Expert Panel ...
Medications
15 hours ago |
not rated yet |
0
Patients to benefit from better advice on pain control
New UK guidance for doctors and other prescribers on the use of strong painkillers for patients with chronic or incurable disease has been welcomed by researchers at the University of Leeds.
Medications
20 hours ago |
not rated yet |
0
Spatial configuration can spark deja vu, psychology study reveals
(Medical Xpress) -- Déjà vu - that strange feeling of having experienced something before - is more likely to occur when a scene's spatial layout resembles one in memory, according to groundbreaking new research ...
New genetic method pinpoints geographic origin
(Medical Xpress) -- Understanding the genetic diversity within and between populations has important implications for studies of human disease and evolution. This includes identifying associations between genetic variants ...
A revealing hand
What did you have for lunch yesterday? How many times a month do you eat nuts? How about your kids -- how many servings of vegetables did they consume today?
World's biggest stroke clot-buster trial reveals patient benefits
(Medical Xpress) -- Patients given a clot-busting drug within six hours of a stroke are more likely to make a better recovery than those who do not receive the treatment, new research has found.
Expert: Medicaid cuts will hurt low-, middle-income Illinois seniors
(Medical Xpress) -- Springfield’s plan to slash nearly $1.4 billion from the state’s Medicaid program will ultimately result in bigger medical (and financial) problems for low- and middle-income ...
Professor conducting study to determine whether supplements help muscles grow
Nutritional supplements are often associated with athletes and body builders, but a University of Kansas professor is conducting a research project to determine whether they are in fact, effective and if they might be able ...
